TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event

Insider Trading

Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.

All Recent Buys Recent Sells
Reset
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).
Ticker Insider Title Date Transaction Price ($) Shares Value ($) SEC Form 4
CORT Maduck Sean See Remarks 11/03/2026 Verkauf 82.68 4,542 375,513 Form 4
CORT Maduck Sean See Remarks 11/03/2026 Verkauf 82.02 8,617 706,765 Form 4
CORT Maduck Sean See Remarks 11/03/2026 Optionsausübung 8.27 13,159 108,825 Form 4
CORT Maduck Sean See Remarks 11/02/2026 Verkauf 81.42 11,841 964,074 Form 4
CORT Maduck Sean See Remarks 11/02/2026 Optionsausübung 8.27 11,841 97,925 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 11/02/2026 Verkauf 81.52 1,676 136,632 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 11/02/2026 Verkauf 80.73 6,657 537,437 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 11/02/2026 Optionsausübung 21.63 8,333 180,243 Form 4
CORT Wilson James N Director 10/15/2026 Verkauf 116.30 300 34,889 Form 4
CORT Wilson James N Director 10/15/2026 Verkauf 115.39 3,046 351,476 Form 4
CORT Wilson James N Director 10/15/2026 Verkauf 114.48 6,654 761,717 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 10/02/2026 Verkauf 116.59 5,147 600,063 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 10/02/2026 Verkauf 115.73 2,086 241,412 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 10/02/2026 Verkauf 114.52 1,100 125,973 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 10/02/2026 Optionsausübung 21.63 8,333 180,243 Form 4
CORT Lyon Joseph Douglas See Remarks 10/02/2026 Verkauf 116.54 4,744 552,869 Form 4
CORT Lyon Joseph Douglas See Remarks 10/02/2026 Verkauf 115.70 4,446 514,389 Form 4
CORT Lyon Joseph Douglas See Remarks 10/02/2026 Optionsausübung 19.26 5,833 112,344 Form 4
CORT Lyon Joseph Douglas See Remarks 10/02/2026 Optionsausübung 13.56 3,357 45,521 Form 4
CORT Maduck Sean See Remarks 10/02/2026 Verkauf 116.55 8,744 1,019,143 Form 4
CORT Maduck Sean See Remarks 10/02/2026 Verkauf 116.12 15,843 1,839,741 Form 4
CORT Maduck Sean See Remarks 10/02/2026 Optionsausübung 8.27 24,587 203,334 Form 4
CORT Lyon Joseph Douglas See Remarks 10/01/2026 Verkauf 115.40 810 93,473 Form 4
CORT Lyon Joseph Douglas See Remarks 10/01/2026 Optionsausübung 13.56 810 10,984 Form 4
CORT Maduck Sean See Remarks 10/01/2026 Verkauf 115.54 413 47,717 Form 4
CORT Maduck Sean See Remarks 10/01/2026 Optionsausübung 8.27 413 3,416 Form 4
CORT Robb Gary Charles Chief Business Officer 09/24/2026 Schenkung — 5,000 — Form 4
CORT Robb Gary Charles Chief Business Officer 09/24/2026 Schenkung — 17,100 — Form 4
CORT Robb Gary Charles Chief Business Officer 09/17/2026 Optionsausübung 8.27 17,493 144,667 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/16/2026 Verkauf 100.82 296 29,843 Form 4
CORT Wilson James N Director 09/15/2026 Verkauf 111.70 2,800 312,771 Form 4
CORT Wilson James N Director 09/15/2026 Verkauf 110.84 400 44,335 Form 4
CORT Wilson James N Director 09/15/2026 Verkauf 110.27 6,800 749,835 Form 4
CORT Lyon Joseph Douglas See Remarks 09/14/2026 Verkauf 114.12 2,188 249,686 Form 4
CORT Lyon Joseph Douglas See Remarks 09/14/2026 Verkauf 113.32 7,812 885,261 Form 4
CORT Lyon Joseph Douglas See Remarks 09/14/2026 Optionsausübung 13.56 7,404 100,398 Form 4
CORT Lyon Joseph Douglas See Remarks 09/14/2026 Optionsausübung 11.35 2,596 29,465 Form 4
CORT Maduck Sean See Remarks 09/02/2026 Steuer-Abgabe 113.38 117 13,265 Form 4
CORT Mokari Atabak Chief Financial Officer 09/02/2026 Steuer-Abgabe 113.38 102 11,565 Form 4
CORT Robb Gary Charles Chief Business Officer 09/02/2026 Steuer-Abgabe 113.38 91 10,318 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/02/2026 Verkauf 115.44 1,225 141,413 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/02/2026 Verkauf 114.58 5,621 644,042 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/02/2026 Verkauf 113.72 1,606 182,632 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/02/2026 Verkauf 112.40 974 109,474 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/02/2026 Verkauf 111.37 1,537 171,181 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/02/2026 Verkauf 110.70 23,770 2,631,349 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/02/2026 Verkauf 109.35 23,600 2,580,674 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/02/2026 Optionsausübung 21.63 58,333 1,261,743 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/02/2026 Steuer-Abgabe 113.38 102 11,565 Form 4
CORT Lyon Joseph Douglas See Remarks 09/02/2026 Steuer-Abgabe 113.38 72 8,163 Form 4
CORT Guyer William Chief Development Officer 09/01/2026 Zuteilung — 164 — Form 4
CORT Maduck Sean See Remarks 09/01/2026 Zuteilung — 150 — Form 4
CORT Maduck Sean See Remarks 09/01/2026 Verkauf 115.61 2,281 263,711 Form 4
CORT Maduck Sean See Remarks 09/01/2026 Verkauf 114.71 10,989 1,260,568 Form 4
CORT Maduck Sean See Remarks 09/01/2026 Verkauf 113.94 11,730 1,336,459 Form 4
CORT Maduck Sean See Remarks 09/01/2026 Optionsausübung 8.27 25,000 206,750 Form 4
CORT Mokari Atabak Chief Financial Officer 09/01/2026 Zuteilung — 138 — Form 4
CORT Robb Gary Charles Chief Business Officer 09/01/2026 Zuteilung — 164 — Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 09/01/2026 Zuteilung — 138 — Form 4
CORT Lyon Joseph Douglas See Remarks 09/01/2026 Zuteilung — 130 — Form 4

A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).

Was this page helpful to you?